Evidence map›Paper›PMID 42622583›Full record

ArticleJACC. Case reports2026

Pulmonary Veno-Occlusive Disease Presenting as Congenital Heart Disease-Associated Pulmonary Hypertension.

Takanori Suzuki, Satoru Kawai, Satona Tanaka, Hidetoshi Uchida, Hiromu Ukai, Yoji Nomura, Hiroyuki Katsuragawa, Jun-Ichi Kawada, Shuichiro Yoshida

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Takanori SuzukiDepartment of Pediatrics, Kariya Toyota General Hospital, Aichi, Japan; Department of Pediatric Cardiology, Aichi Children's Health and Medical Center, Aichi, Japan; Department of Pediatrics, School of Medicine, Fujita Health University, Aichi, Japan. Electronic address: takanori-s@axel.ocn.ne.jp.
Satoru KawaiDepartment of Pediatric Cardiology, Aichi Children's Health and Medical Center, Aichi, Japan.
Satona TanakaDepartment of Thoracic Surgery, Kyoto University Hospital, Kyoto, Japan.
Hidetoshi UchidaDepartment of Pediatrics, School of Medicine, Fujita Health University, Aichi, Japan.
Hiromu UkaiDepartment of Pediatric Cardiology, Aichi Children's Health and Medical Center, Aichi, Japan.
Yoji NomuraDepartment of Pediatric Cardiology, Aichi Children's Health and Medical Center, Aichi, Japan.
Hiroyuki KatsuragawaDepartment of Diagnostic Pathology, Kyoto University Hospital, Kyoto, Japan.
Jun-Ichi KawadaDepartment of Pediatrics, School of Medicine, Fujita Health University, Aichi, Japan.
Shuichiro YoshidaDepartment of Pediatric Cardiology, Aichi Children's Health and Medical Center, Aichi, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPulmonary veno-occlusive disease (PVOD) is a rare cause of pulmonary hypertension rarely linked to congenital heart disease (CHD). CASE SUMMARY: An infant with a ventricular septal defect developed pulmonary hypertension. At 3 months, cardiac catheterization showed operable hemodynamics with preserved pulmonary vasoreactivity. Pulmonary artery banding was performed. Despite tadalafil, macitentan, and prostacyclin, pulmonary vascular resistance increased without pulmonary edema. Lung perfusion scintigraphy demonstrated perfusion defects, prompting transplantation. At 2 years and 10 months, he underwent bilateral lung transplantation with intracardiac repair. The explanted lungs demonstrated fibrous intimal thickening of pulmonary venules and hemosiderin deposition, indicating PVOD. DISCUSSION: PVOD may coexist with CHD and mimic CHD-associated pulmonary arterial hypertension, without pulmonary edema during vasodilator therapy. TAKE-HOME MESSAGES: PVOD should be considered in children with CHD developing progressive pulmonary hypertension despite favorable hemodynamics and preserved vasoreactivity. The absence of pulmonary edema during vasodilator therapy does not exclude PVOD.

Indexed as

lung transplantationpulmonary hypertensionpulmonary veno-occlusive diseaseventricular septal defect

Identifiers

PMID42622583
PMCPMC13669881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.